The 2020 World Health Assembly(WHA) was held in a?special?period?of?time?when the outbreak of?COVID-19 put?the world in a complex situation, and the pandemic is?still spreading worldwide. Therefore, “how the world?responds?to the most serious global public health emergency since the end of WWII”,?has become the?focus of?discussion in the?international community.?
On May 22, Ms.Beate Trankmann, UNDP(United Nations Development Programme)Resident Representative in China, was interviewed by mail. During the interview, Ms.Beate Trankmann responded to three questions around the contribution that China has made for the 2030 Agenda for Sustainable Development through its achievement in poverty reduction.
To China, 2020 is definitely a year to remember. A moderately prosperous society in all respects is to be built with major progress toward a decisive victory;the Chinese nation reaches the milestone for conquering poverty as extreme poverty is to be eradicated completely. The achievement is also quite meaningful to the whole world.
The fourth plenary session of the 19th Central Committee of the Communist Party of China (CPC), held last October, decided to develop a new type of national system for breakthroughs in core technologies under the conditions of the socialist market economy.
China is a model for making its vision to lead global innovation.China leads the development of infrastructure for an advanced technological environment, and the number of its people’s use of technologies and applications increases every year. In many fields, China is also a role model for global innovation.
The Chinese Consulate General in Los Angeles on April 10 invited Zhang Boli, an academician of the Chinese Academy of Engineering and president of Tianjin University of Traditional Chinese Medicine, to speak live over the internet with students and overseas Chinese in the U.S. on how to use Traditional Chinese Medicine (TCM) to prevent and treat COVID-19.
Around the time of the 2020 Spring Festival, Ma Juncai, a researcher at the Institute of Microbiology, Chinese Academy of Sciences (CAS), and Wei Qiang from the Chinese Center for Disease Control and Prevention (China CDC), got together to brainstorm ideas about how to develop a support system for COVID-19 related research by leveraging strengths of both sides.
Is there any specific drug to fight against COVID-19? When can we get access to the specific drug? These two questions are hard to answer for now. Developing the specific drug is quite tough. It is? not practical when R&D works of new drugs usually takes too long and costs too much.
According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.
Beijing Municipal People's Government, National Development and Reform Commission, the Ministry of Science and Technology and the Ministry of Industry and Information Technology will jointly hold the first World 5G Convention in Beijing Economic-Technological Development Area from November 20 to 23, 2019. The Convention aims to seize the opportunities brought by 5G technological innovation and industry reform, collect quality innovation resources and advance the growth and application of 5G. It also intends to expedite the commercialization of 5G and boost the exchange and joint advances of global 5G technologies.
Roxadustat, a new drug used for treating anemia of chronic kidney disease, has recently been recognized by top international academia. It is expected to lead the revolutionary change in the treatment mode of renal anemia.
In the preliminary meeting of operating the regional research center, International Centre for Genetic Engineering Biotechnology (ICGEB) in China, Science and Technology Daily was informed that China Medical City (CMC), China's leading medical industrialization base in Taizhou, Jiangsu Province, was invited by ICGEB to discuss the promotion and collaboration between CMC and ICGEB.